has been associated with a higher risk of developing cardiovascular diseases, metabolic disorders and other comorbidities. Patients surgically treated for renal cell carcinoma (RCC) are at risk of developing chronic kidney disease (CKD) over time. Detecting those at higher risk of CKD is crucial for an adequate treatment and follow-up planning. We tested the association between preoperative ED and the risk of developing CKD after surgery for RCC.
INTRODUCTION AND OBJECTIVES: Erectile dysfunction (ED)
has been associated with a higher risk of developing cardiovascular diseases, metabolic disorders and other comorbidities. Patients surgically treated for renal cell carcinoma (RCC) are at risk of developing chronic kidney disease (CKD) over time. Detecting those at higher risk of CKD is crucial for an adequate treatment and follow-up planning. We tested the association between preoperative ED and the risk of developing CKD after surgery for RCC.
METHODS: A total 106 male patients surgically treated for RCC at a single center, between 2012 and 2018, had available preoperative erectile function (EF) data. Preoperative EF was assessed with the International Index of Erectile Function-EF (IIEF-EF). This questionnaire is routinely administered at our center to RCC patients aged <[70 years. Patients were submitted to either partial (PN) or radical nephrectomy (RN) according to clinical stage. After surgery, they were routinely assessed every 6 months for the first 2 years and annually thereafter; estimated glomerular filtration rate (eGFR) CONCLUSIONS: Erectile dysfunction is a common disorder among patients with RCC. Those with severe ED depicted 3-fold higher risk of developing postoperative CKD. Preoperative EF status may be an additional factor to be considered for treatment planning and follow-up of patients with RCC. METHODS: We identified all men who underwent a robotic radical prostatectomy from May 2014-January 2016 in the Michigan Urological Surgery Improvement Collaborative (MUSIC). A single item from the PROMIS Global Satisfaction with Sex Life subdomain (When you have had sexual activity, how satisfying has it been?) and the PROMIS Interest in Sexual Activity subdomain (How interested have you been in sexual activity?) was administered. The MSKCC STAR system was also administered to assess sexual function. Convergent and discriminant validity and in between group differences were evaluated.
RESULTS: A total of 1,604 participants were examined in this analysis. The mean age was 63.21. Convergent and discriminant validity of the PROMIS SexFS Interest in Sexual Activity and Satisfaction with Sex Life single item measures were supported in this study. The mean PROMIS Interest in Sexual Activity T score decreased significantly from baseline to 3 months (p[.0014) and significantly increased from 3 to 24 months (p<.0001) (Figure 1 ). The mean PROMIS Global Satisfaction with Sex Life T score declined from baseline to 3 months (p<.0001) and increased from 3 to 24 months (p[.0018) (Figure 1) . CONCLUSIONS: Our findings suggest that patients are interested in sex despite functional losses and can salvage satisfaction, thereby giving insight into attainable patient-centered survivorship goals for sexual recovery following radical prostatectomy. These measures have the potential to add an important element to survivorship care and can impart self-efficacy onto the prostate cancer survivor.
